PRDM9 activity depends on HELLS and promotes local 5-hydroxymethylcytosine enrichment

  1. Yukiko Imai
  2. Mathilde Biot
  3. Julie Clément
  4. Mariko Teragaki
  5. Serge Urbach
  6. Thomas Robert
  7. Frédéric Baudat
  8. Corinne Grey
  9. Bernard de Massy  Is a corresponding author
  1. National Institute of Genetics, Japan
  2. CNRS UM, France
  3. CNRS INSERM UM, France

Abstract

Meiotic recombination starts with the formation of DNA double-strand breaks (DSBs) at specific genomic locations that correspond to PRDM9 binding sites. The molecular steps occurring from PRDM9 binding to DSB formation are unknown. Using proteomic approaches to find PRDM9 partners, we identified HELLS, a member of the SNF2-like family of chromatin remodelers. Upon functional analyses during mouse male meiosis, we demonstrated that HELLS is required for PRDM9 binding and DSB activity at PRDM9 sites. However, HELLS is not required for DSB activity at PRDM9-independent sites. HELLS is also essential for 5-hydroxymethylcytosine (5hmC) enrichment at PRDM9 sites. Analyses of 5hmC in mice deficient for SPO11, which catalyzes DSB formation, and in PRDM9 methyltransferase deficient mice reveal that 5hmC is triggered at DSB-prone sites upon PRDM9 binding and histone modification, but independent of DSB activity. These findings highlight the complex regulation of the chromatin and epigenetic environments at PRDM9-specified hotspots.

Data availability

PRIDE partner repository with the dataset identifier PXD017337. NGS data have been deposited at GEO under series record GSE145768. Source data have been provided for Figure 2C-D and Figure 3G

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Yukiko Imai

    Department of Gene Function and Phenomics, National Institute of Genetics, Mishima, Japan
    Competing interests
    No competing interests declared.
  2. Mathilde Biot

    Institute of Human Genetics UMR9002, CNRS UM, Montpellier, France
    Competing interests
    No competing interests declared.
  3. Julie Clément

    Institut de Génétique Humaine, CNRS UM, Montpellier, France
    Competing interests
    No competing interests declared.
  4. Mariko Teragaki

    Institute of Human Genetics UMR9002, CNRS UM, Montpellier, France
    Competing interests
    No competing interests declared.
  5. Serge Urbach

    Institut de Génomique Fonctionnelle, CNRS INSERM UM, Montpellier, France
    Competing interests
    No competing interests declared.
  6. Thomas Robert

    Centre de Biologie Structurale, CNRS INSERM UM, Montpellier, France
    Competing interests
    No competing interests declared.
  7. Frédéric Baudat

    Institute of Human Genetics, CNRS UPR1142, CNRS UM, Montpellier, France
    Competing interests
    No competing interests declared.
  8. Corinne Grey

    Institute of Human Genetics UMR9002, CNRS UM, Montpellier, France
    Competing interests
    No competing interests declared.
  9. Bernard de Massy

    Institute of Human Genetics UMR9002, CNRS UM, Montpellier, France
    For correspondence
    bernard.de-massy@igh.cnrs.fr
    Competing interests
    Bernard de Massy, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0950-2758

Funding

ERC (322788)

  • Bernard de Massy

MSDAVenir (Gene-IGH)

  • Bernard de Massy

Fondation Bettencourt Schueller

  • Bernard de Massy

Fondation pour la Recherche Médicale

  • Mathilde Biot

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experiments were carried out according to the CNRS guidelines and were approved by the ethics committee on live animals (project CE-LR-0812 and 1295).

Copyright

© 2020, Imai et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,191
    views
  • 360
    downloads
  • 23
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Yukiko Imai
  2. Mathilde Biot
  3. Julie Clément
  4. Mariko Teragaki
  5. Serge Urbach
  6. Thomas Robert
  7. Frédéric Baudat
  8. Corinne Grey
  9. Bernard de Massy
(2020)
PRDM9 activity depends on HELLS and promotes local 5-hydroxymethylcytosine enrichment
eLife 9:e57117.
https://doi.org/10.7554/eLife.57117

Share this article

https://doi.org/10.7554/eLife.57117

Further reading

    1. Chromosomes and Gene Expression
    Carlos Moreno-Yruela, Beat Fierz
    Insight

    Specialized magnetic beads that bind target proteins to a cryogenic electron microscopy grid make it possible to study the structure of protein complexes from dilute samples.

    1. Chromosomes and Gene Expression
    2. Structural Biology and Molecular Biophysics
    Liza Dahal, Thomas GW Graham ... Xavier Darzacq
    Research Article

    Type II nuclear receptors (T2NRs) require heterodimerization with a common partner, the retinoid X receptor (RXR), to bind cognate DNA recognition sites in chromatin. Based on previous biochemical and overexpression studies, binding of T2NRs to chromatin is proposed to be regulated by competition for a limiting pool of the core RXR subunit. However, this mechanism has not yet been tested for endogenous proteins in live cells. Using single-molecule tracking (SMT) and proximity-assisted photoactivation (PAPA), we monitored interactions between endogenously tagged RXR and retinoic acid receptor (RAR) in live cells. Unexpectedly, we find that higher expression of RAR, but not RXR, increases heterodimerization and chromatin binding in U2OS cells. This surprising finding indicates the limiting factor is not RXR but likely its cadre of obligate dimer binding partners. SMT and PAPA thus provide a direct way to probe which components are functionally limiting within a complex TF interaction network providing new insights into mechanisms of gene regulation in vivo with implications for drug development targeting nuclear receptors.